Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07209878 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

68Ga-PSMA-11 PET Imaging for Diagnosing Prostate Cancer, a Head-to-head Comparison With mpMRI

Name: 68Ga-PSMA-11 PET Imaging for Diagnosing Prostate Cancer, a Head-to-head Comparison With mpMRI — clinical trial record (NCT07209878)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhasePhase 2/3

SponsorFirst Affiliated Hospital of Fujian Medical University

Started2020-01-10

View on ClinicalTrials.gov ↗

Record status

This record was last updated October 7, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.

First Affiliated Hospital of Fujian Medical University

56 trials monitored

See all monitored trials

Prostate Cancer

2,471 trials monitored

See 156 trials at risk

68Ga-PSMA-11 is a widely used radiotracer targeting PSMA. In this study, we investigated the diagnostic efficacy of 68Ga-PSMA-11 PET imaging (PET/CT or PET/MRI) in patients with newly diagnosed, treatment-naive prostate cancer, and performed a head-to-head comparison with multi-parameter magnetic resonance imaging (mpMRI).

Trial Details

NCT Number	NCT07209878
Lead Sponsor	First Affiliated Hospital of Fujian Medical University
Conditions	Prostate Cancer (Adenocarcinoma)
Enrollment	100 participants
Start Date	2020-01-10
Primary Completion	2025-12-31 (estimated)
Study Completion	2026-06-30 (estimated)
Updated on ClinicalTrials.gov	2025-10-07